Related Experiment Video
Updated: Jan 21, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Management of asthma COPD overlap.
Diego Jose Maselli1, Nicola Alexander Hanania2
1Division of Pulmonary Diseases & Critical Care Medicine, Department of Medicine, University of Texas Health at San Antonio, San Antonio, Texas.
Asthma COPD overlap (ACO) patients face higher risks. Initial treatment should combine long-acting bronchodilators with inhaled corticosteroids, with long-acting muscarinic antagonists as add-on therapy for better management.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Asthma COPD overlap (ACO) is associated with increased patient morbidity compared to asthma or COPD alone.
- Limited evidence exists for optimal therapeutic strategies in ACO patients due to exclusion from major clinical trials.
- Current management guidelines are largely based on expert consensus and strategy documents.
Purpose of the Study:
- To review the latest literature on management approaches for patients with asthma COPD overlap (ACO).
- To synthesize current understanding of ACO patient treatment based on available studies and expert recommendations.
Main Methods:
- Literature search conducted across PubMed/Medline, ClinicalTrials.gov, and the Cochrane Register of Controlled Trials.
- Inclusion of studies focusing on the management of asthma, COPD, and ACO.
- Review of existing data to identify current therapeutic recommendations and gaps in knowledge.
Main Results:
- Patients with ACO exhibit greater morbidity than those with isolated asthma or COPD.
- Initial ACO therapy should include a long-acting bronchodilator with inhaled corticosteroids, avoiding long-acting beta-agonist monotherapy.
- Long-acting muscarinic antagonists are effective in both asthma and COPD and are recommended as add-on therapy for ACO.
Conclusions:
- Prospective studies evaluating ACO-specific therapies are scarce.
- Future research should focus on phenotyping and identifying treatable traits to optimize ACO management strategies.
- Personalized treatment approaches are essential for effectively managing patients with asthma COPD overlap.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

